Bigtincan Hub Earns Prestigious Industry Recognition Bigtincan (ASX: BTH), the global leader in sales enablement automation, has been named the best Sales Enablement Platform of 2020 as part of the annual SIIA CODiE Awards. The prestigious CODiE Awards recognize the companies producing the most innovative business technology products across the country, and around the world. “Our vision of helping every customer-facing person be more confident and effective is even more important as our whole world becomes more digital and mobile,” said David Keane, CEO of Bigtincan. “We are proud to help hundreds of thousands of people around the world do…
Author: Marie Jones
Read More
SINGAPORE, May 21, 2020 – (ACN Newswire) – To ensure a safe and smooth exhibition experience amid the latest developments of the coronavirus (COVID-19) situation, the organiser of Singapore Vet – Closerstill Media has postponed the event, originally scheduled on 23-24 October to next year, 2021. “While this decision comes at a time of universal uncertainty, we take the safety and health of our sponsors, partners, staff and community very seriously. We believe by rescheduling the event will enable us to provide a better exhibition / conference experience that our attendees expect and deserve in a safe environment,” said Andy…
Wintermar Offshore Marine (WINS:JK) returned to profitability during 1Q2020 with Owned Vessel Revenue up 18% YoY to US$9.9 million, and gross profit of US$1.28 million compared to a gross loss of US$0.73 million during 1Q2019. The quarter saw a pick up in utilization of high tier vessels as several new contracts commenced, lifting the average utilization of the fleet to 68% compared to only 46% a year ago. The Company turned positive in gross and net profit for the first time in three years. -Owned Vessel Division- Continuing the uptrend in offshore activity for 1Q2020 which began in 2019, the…
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for biotech clinical trials, is presenting the Australian Advantage including the world’s most attractive rebate on clinical trials costs, at BIO Korea 2020. The presentation by Kurt Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM) Director, Immunoassay at Agilex Biolabs, also detailed how well the Australian clinical trials industry had managed during the COVID-19 crisis with most sites, CROs, and labs including Agilex Biolabs, staying open. The presentation is at 13.50 on Friday 22, May 2020 via the virtual conference platform. https://www.biokorea.org/index.asp Agilex Biolabs also launched a News Video Update on the COVID-19 impact…
NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announced today that strong effectiveness against infection by an ACE2-utilizing coronavirus in an animal model has been observed for the drug candidates it is developing against SARS-CoV-2 to treat COVID-19 spectrum of diseases. NanoViricides is developing an animal model for coronavirus infection using hCoV-NL63 as a surrogate for SARS-CoV-2, the virus that causes COVID-19 disease. HCoV-NL63 is a circulating human coronavirus that causes a disease that is similar to SARS-CoV-2, but much milder. Both viruses utilize the…
領先的亞太地區專業生物技術CRO Novotech 已被《生命科學領袖》(Life Science Leader) 雜誌授予享譽盛名的“CRO 領導力大獎”，該獎項是基於使用外包服務的申辦者公司的調查結果得出的。 https://www.croleadershipawards.com/ 特別值得稱道的是，Novotech 因為達到或超出客戶的期望而獲得認可。這是 Novotech 榮膺《生命科學領袖》(Life Science Leader) 頒發的第二個獎項。 申辦方根據最近的外包項目對 CRO 進行評分。對 60 個合同研究組織進行了多維度的評估。 作為從生物製藥角度對 CRO 行業進行詳細審查的一部分，《生命科學領袖》(Life Science Leader) 將 Novotech 評選為多個關鍵領域的領袖，包括： 1. 與生物製藥公司的相容性 2. 能力 3. 質量 4. 可靠性 “與臨床運營總監交談時，我被告知 CRO 選擇過程可能是他們最具壓力和最耗時的工作之一，”Clinical Leader 總編輯 Ed Miseta 表示。 “我們想方設法將讀者引向最能滿足其需求的合作夥伴，從而可以大幅減輕他們的搜索負擔。這就是我們再次自豪地與 Industry Standard Research 合作產生我們的年度“CRO 領導力大獎”的原因。 獲此殊榮的組織已經證明了自己是“相容性、能力、質量和可靠性”方面的領跑者。我們讚賞這些公司為滿足製藥和生物技術客戶的需求及期望而付出的辛勤工作。 ” Novotech 首席執行官 John Moller 博士表示，他很高興 Novotech 因其在亞太地區的專業技能而得到生物技術行業的認可。 “沒有什麼比申辦方在開展臨床試驗所需的各個核心維度舉薦 Novotech 更有說服力的了。” Moller 博士補充表示：“Novotech 在本地區繼續保持強勁增長，大多數亞太國家都正在擺脫 COVID-19 危機，而且大多數研究中心運行正常。” 關於Novotech – https://novotech-cro.com Novotech的總部位於悉尼，是一家國際公認的領先的區域全方位服務合同研究機構(CRO)。迄今為止Novotech已在亞太地區成功協助進行了數百次I – IV期臨床試驗。 Novotech在所有臨床試驗階段和治療領域提供臨床開發服務，包括：可行性評估；向倫理委員會和監管機構提交文件，數據管理，統計分析，醫療監控，安全服務，中央實驗室服務，針對ICH要求的報告撰寫，項目和供應商管理。 Novotech在亞太地區的強大實力體現在，在所有主要的區域市場進行臨床試驗，另外它還通過公司的戰略合作夥伴網絡在全球範圍內尋求發展。 如需查詢徵詢方案： 請在 https://novotech-cro.com/talk-to-an-expert 上填寫表格。 媒體聯繫人 Susan Fitzpatrick-Napier communications@novotech-cro.com 澳大利亞: +61 2 8218 2144 美國: +1 415 951 3228 亞洲: +65 3159 3427
领先的亚太地区专业生物技术 CRO Novotech 已被《生命科学领袖》(Life Science Leader) 杂志授予享誉盛名的“CRO 领导力大奖”，该奖项是基于使用外包服务的申办者公司的调查结果得出的。https://www.croleadershipawards.com/ 特别值得称道的是，Novotech 因为达到或超出客户的期望而获得认可。这是 Novotech 荣膺《生命科学领袖》(Life Science Leader) 颁发的第二个奖项。 申办方根据最近的外包项目对 CRO 进行评分。对 60 个合同研究组织进行了多维度的评估。 作为从生物制药角度对 CRO 行业进行详细审查的一部分，《生命科学领袖》(Life Science Leader) 将 Novotech 评选为多个关键领域的领袖，包括： 1. 与生物制药公司的相容性 2. 能力 3. 质量 4. 可靠性 “与临床运营总监交谈时，我被告知 CRO 选择过程可能是他们最具压力和最耗时的工作之一，”Clinical Leader 总编辑 Ed Miseta 表示。 “我们想方设法将读者引向最能满足其需求的合作伙伴，从而可以大幅减轻他们的搜索负担。这就是我们再次自豪地与 Industry Standard Research 合作产生我们的年度“CRO 领导力大奖”的原因。 获此殊荣的组织已经证明了自己是“相容性、能力、质量和可靠性”方面的领跑者。我们赞赏这些公司为满足制药和生物技术客户的需求及期望而付出的辛勤工作。” Novotech 首席执行官 John Moller 博士表示，他很高兴 Novotech 因其在亚太地区的专业技能而得到生物技术行业的认可。 “没有什么比申办方在开展临床试验所需的各个核心维度举荐 Novotech 更有说服力的了。” Moller 博士补充表示：“Novotech 在本地区继续保持强劲增长，大多数亚太国家都正在摆脱 COVID-19 危机，而且大多数研究中心运行正常。” 关于Novotech – https://novotech-cro.com Novotech的总部位于悉尼，是一家国际公认的领先的区域全方位服务合同研究机构(CRO)。迄今为止Novotech已在亚太地区成功协助进行了数百次I – IV期临床试验。Novotech在所有临床试验阶段和治疗领域提供临床开发服务，包括：可行性评估；向伦理委员会和监管机构提交文件，数据管理，统计分析，医疗监控，安全服务，中央实验室服务，针对ICH要求的报告撰写，项目和供应商管理。Novotech在亚太地区的强大实力体现在，在所有主要的区域市场进行临床试验，另外它还通过公司的战略合作伙伴网络在全球范围内寻求发展。 如需查询征询方案： 请在 https://novotech-cro.com/talk-to-an-expert 上填写表格。 媒体联系人 Susan Fitzpatrick-Napier communications@novotech-cro.com 澳大利亚: +61 2 8218 2144 美国: +1 415 951 3228 亚洲: +65 3159 3427
OmniSci, the pioneer in accelerated analytics, announced today that the company posted its highest-ever revenue for a quarter, closing deals with major new customers, strengthening key partnerships, and expanding the company’s global reach. OmniSci’s strong Q1 performance provides significant momentum for Q2 and beyond. Following the company’s expansion into Europe last year, in April, OmniSci expanded into Asia to meet growing global demand for its analytics capabilities. The company brought Joseph (Joe) Lee on board as VP of Global Sales and welcomed Herfini Haryono, former CTIO at PT Telkomsel and CIO at Indosat Ooredoo in Indonesia, to the team as…
Leading payment-based technology platform, Providing payment and business services to merchants and consumers, Offer price between HK$12.64 and HK$16.64 per share YEAHKA LIMITED (“Yeahka” or the “Company”, together with its subsidiaries, the “Group”, stock code: 9923.HK), a leading payment-based technology platform in China, announced the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (“SEHK”) today. YEAHKA LIMITED plans to offer an aggregate of 98,724,000 Offer Shares under the Global Offering (subject to the Over-allotment Option), consisting of 88,851,200 International Offer Shares (subject to adjustment and the Over-allotment Option) and 9,872,800 Hong…
Greenbriar Capital Corp. (TSXV: GRB) (OTC: GEBRF) (“Greenbriar”) is pleased to announce the following statement from our legal counsel in Washington, DC. Luis Baco, JD, LLM, states: “Greenbriar Capital Corp (“Greenbriar”) is pleased to announce that it has reached agreement with the Puerto Rico Electric Power Authority (PREPA) on a 25-year Power Purchase and Operating Agreement (PPOA) for the development, construction, and operation of the 80MW to 160MW AC Montalva solar project. The Montalva PPOA now moves on to final approval by the Puerto Rico Energy Bureau (PREB) and the Puerto Rico Financial Oversight and Management Board (FOMB). This process…
Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development (“R&D”) driven pharmaceutical conglomerate in the PRC, has announced that the abstracts on phase II study on clinical efficacy and safety of Penpulimab (AK105, PD-1 monoclonal antibody) it jointly developed and commercialized with Akeso, Inc. (“Akeso”, HKEX:9926) in combination with Anlotinib for first-line treatment of advanced hepatocellular carcinoma (“1L HCC”), have been accepted for poster presentation at the upcoming 2020 American Society of Clinical Oncology (“ASCO”) Annual Meeting. As of to date, various phase II/III studies on combination of Penpulimab with Anlotinib have been activated, regarding treatment of various…
In the wake of the COVID-19 crisis, Aetna Insurance has extended its coverage of cell-free DNA screening tests, previously reserved for pregnant women over 35, to all expectant mothers. While Aetna has taken an encouraging step towards safeguarding maternal health during the COVID-19 pandemic, Stand Up! 4APA urges the insurance provider to make this policy change permanent. The organization also expects other insurance providers, including UnitedHealthcare, to promptly follow Aetna’s example. Following updated Society for Maternal Fetal Medicine (SMFM) Ultrasound Practice Suggestions and COVID-19 MFM Guidance published in AJOG-MFM, Aetna is taking steps towards containing the spread of Coronavirus by…
The Hong Kong Institute of Directors (“HKIoD”) has today announced the results of the “2020 HKIoD Corporate Governance Scorecard”. A highlight is that the mean Corporate Governance Index (CGI) score of the 2020 Scorecard has increased to 78.44 compared with 71.82, in the most recent survey announced in 2016, indicating significant improvement in Hong Kong corporate governance standards. In line with the survey results, HKIoD recommends that companies should aim to move from minimum compliance to more actively implement best practices. Besides, HKIoD advises listed companies that greater disclosure as a self-initiative drives better corporate governance. Since 2004, the Scorecard…
NIU Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced its financial results for Q1 2020. Road to Recovery with a Revenue of RMB 232.9 Million For Q1 2020, the revenue is RMB 232.9 million, which decreased by 34.4% YoY due to lower sales volume. The total number of e-scooters sold worldwide was 40,160 units, decreased by 39.4% YoY, which is attributed to the damaging effects of the global pandemic. The number of e-scooters sold in China reached 34,316 units, decreased by 43.5% YoY. On the other hand, the number of…
Renown digital asset custody provider Onchain Custodian today announced a strategic collaboration with CyberBank. Onchain Custodian’s secure, compliant custody solution will aid CyberBank’s trading platform business in meeting with regulatory compliance. CyberBank is a leading digital finance technology group in Asia and is the first to build a model that combines an exchange, custody services provider and investment funds. CyberBank has strong liquidity and funding, which powers its digital asset trading services and trading cloud service business. Through its collaboration with Onchain Custodian, CyberBank completes its business offerings, by tapping on Onchain Custodian’s expertise in custody of digital assets. CyberBank…
Virtual Electronics PTE LTD, a Singapore-registered outsourcing software development company, has launched a new smart collaboration services platform, VEnterface. The platform aims to facilitate collaboration among innovative Singaporean and Australian entrepreneurs, and improve their decision making using data discovery and data leveraging.Dr. Victor Paul, Senior Representative of Virtual Electronics PTE VEnterface platform features include: – Tools to estimate different innovative market entry variants (Algorithmic business) – Higher visibility of collaborators on the platform (Matching service) – Data-driven procedures to make well-weighted decisions on collaborations (Data-driven business) – A platform-based community for cooperation and partnering (Opportunities of sharing economy) Businesses in…
BEIJING – (ACN Newswire) – Since 2018, bond index funds have delivered an eye-catching performance as the bond market goes bullish, and bond index fund products have reported an exponential growth in not only the quantity but also the size, drawing increasing attention from investors. Southern Asset Management, as one of the earliest fund companies in China to develop bond index funds, has scaled up its bond index fund products continuously in recent years. According to Wind and the 1Q product reports, as of 1Q20, bond index funds managed by Southern Asset Management added up to more than RMB30 billion,…
SMC Electric Limited (“SMC Electric” or the “Company”, together with its subsidiaries, collectively referred as the “Group”) has recently announced the details of the proposed listing of its shares on Main Board of The Stock Exchange of Hong Kong Limited (“HKEx”) (the “Share Offer”). Investment Highlights – Long history in the PRC-based electric tools and electric fans export industry. – Stringent quality control. – Established relationships with reputable overseas customers. – Close relationships with customers and reliable suppliers. – Cost effective production operations. – Highly experienced professional management team. SMC Electric plans to offer a total of 500,000,000 shares, subject…
Smartac Group China Holdings Limited (HKEX: 395, “Smartac” or the “Group”) has announced its unaudited operating performance for the three months ended 31 March 2020 (the “Period”). Revenue for the Period reached approximately RMB22.0 million, representing a growth of around 411.6% as compared with approximately RMB4.3 million for the corresponding period of last year and equal to around 85.3% of the annual revenue of approximately RMB25.8 million for 2019. The significant increase in revenue for the Period was mostly attributed to the Group’s strategic focus on developing the e-commerce solutions business through diversification of both its product offerings and client…
– BioStar 2 v2.8 now encrypts every data available as a default feature Suprema, a global leader in security and biometrics, has released a new version BioStar 2 platform, enhancing the cyber security features. Suprema BioStar 2 is a web-based, open, and integrated security platform that provides comprehensive functionality for access control and time & attendance. In addition to existing encryption of personal data, used for authentication with passwords, fingerprint templates and face templates, BioStar 2 now encrypts every data available that may potentially link to any specific individual. With this enhancement in BioStar 2 v2.8, this upscaled security will be…